Evidence mapPaperPMID 41602240Full record

ArticleCureus2025

Diabetes in the African-Caribbean and the Romford Experience (DARE): A Retrospective Study.

Noha Meneissy, Adnan Abdullah, Bhavini Bhatt, Ehsan Shakoor, Furhana Hussein, Zahid Khan, Lina Eltayieb, Bashir Mahamud, Azhar Faisymohammed, Gideon Mlawa

Abstract read
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Noha MeneissyEndocrinology and Diabetes, Barking, Havering and Redbridge University Hospitals NHS Trust, London, GBR.
Adnan AbdullahAcute Medicine, Barking, Havering and Redbridge University Hospitals NHS Trust, London, GBR.
Bhavini BhattMedicine, University College London Medical School, London, GBR.
Ehsan ShakoorInternal Medicine, Queen's Hospital, London, GBR.
Furhana HusseinInternal Medicine and Diabetes and Endocrinology, Barking, Havering and Redbridge University Hospitals NHS Trust, London, GBR.
Zahid KhanCardiology, Barts Health NHS Trust, London, GBR.
Lina EltayiebMedicine, Barking, Havering and Redbridge University Hospitals NHS Trust, London, GBR.
Bashir MahamudInternal Medicine and Diabetes and Endocrinology, Barking, Havering and Redbridge University Hospitals NHS Trust, London, GBR.
Azhar FaisymohammedInternal Medicine, Barking, Havering and Redbridge University Hospitals NHS Trust, London, GBR.
Gideon MlawaInternal Medicine and Diabetes and Endocrinology, Barking, Havering and Redbridge University Hospitals NHS Trust, London, GBR.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDiabetes mellitus is a significant public health challenge in the United Kingdom, with higher prevalence and complication rates among minority ethnic groups, especially those of African and Caribbean descent. Evidence shows that these populations have an increased risk of developing type 2 diabetes and related metabolic issues, often presenting late with acute hyperglycemic emergencies like diabetic ketoacidosis (DKA) or hyperosmolar hyperglycemic state (HHS). Understanding patterns of disease onset and early management in these communities is crucial for reducing health disparities and improving outcomes.

aimThe DARE study aimed to describe the clinical characteristics, presentation patterns, diabetes subtypes, and early management of Afro-Caribbean patients admitted to a hospital in Romford with diabetes or diabetes-related complications. The objectives were to identify the prevalence of diabetes subtypes, assess demographic trends, document acute presentations, and evaluate early inpatient management.

methodsThis retrospective observational study focused on Afro-Caribbean adults who were admitted to Queen's Hospital, Romford, for diabetes or related complications from January 2020 to December 2024. Eligible patients were identified through CareFlow Connect, the London Care Record, and EPRO, applying specific inclusion criteria. In total, 52 individuals comprised the final study group. Descriptive statistics were used to summarise the data, with analysis performed in Microsoft Excel (Redmond, USA) and Google Sheets (California, USA).

resultsThe study cohort included 52 patients (mean age 46 years, range 18 to 86), of whom 33 (63.5%) were male. Type 2 diabetes was the most prevalent subtype (39 of 52, 75.0%), followed by type 1 diabetes (7 of 52, 13.5%) and latent autoimmune diabetes in adults (LADA) (5 of 52, 9.6%). Acute metabolic emergencies were common: diabetic ketoacidosis (DKA) occurred in 20 of 52 patients (38.5%), hyperosmolar hyperglycaemic state (HHS) in 13 of 52 (25.0%), and a mixed DKA/HHS presentation in 1 of 52 (1.9%). Among patients younger than 30 years, 4 of 9 (44.4%) presented with DKA. Non-emergency presentations included hyperglycaemia without ketosis (n = 9) and polyuria or polydipsia (n = 4). Insulin use was frequently documented, with both long-acting and short-acting insulin each recorded in 28 of 52 patients (53.8%). Six patients (11.5%) were identified as deceased in available hospital-linked records; information regarding place of death and complete follow-up outside these records was unavailable.

conclusionIn this admission-based cohort of Afro-Caribbean adults in Romford, acute hyperglycaemic emergencies (DKA/HHS) were common at first hospital presentation, and insulin therapy was frequently recorded. These findings are descriptive and hypothesis-generating and support the need for locally responsive, culturally informed approaches to earlier identification and continuity of diabetes care in high-risk communities. Further multi-centre studies with standardised definitions and improved linkage to community and primary care records are warranted to clarify pathways to diagnosis, barriers to timely care, and the impact and cost-effectiveness of targeted interventions.

Indexed as

afro-caribbeansdiabetesdiabetic ketoacidosis (dka)endocrine disorderstypes 2 diabetes

Identifiers

PMID41602240
PMCPMC12834178

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.